STRS Ohio’s Fennec Pharmaceuticals FENC Stock Holding History

STRS Ohio’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32K	Hold	5,200	–	–	﹤0.01%	2012
2025 Q4	$40K	Hold	5,200	–	–	﹤0.01%	2023
2025 Q3	$48.7K	Buy	+5,200	New	+$45K	﹤0.01%	2011
2021 Q2	–	Sell	-15,500	Closed	-$96K	–	2290
2021 Q1	$96K	Hold	15,500	–	–	﹤0.01%	1951
2020 Q4	$115K	Hold	15,500	–	–	﹤0.01%	1862
2020 Q3	$93K	Hold	15,500	–	–	﹤0.01%	1859
2020 Q2	$129K	Buy	+15,500	New	+$115K	﹤0.01%	1735
2019 Q2	–	Sell	-3,300	Closed	-$14K	–	2139
2019 Q1	$16K	Hold	3,300	–	–	﹤0.01%	1982
2018 Q4	$21K	Hold	3,300	–	–	﹤0.01%	1981
2018 Q3	$27K	Hold	3,300	–	–	﹤0.01%	2010
2018 Q2	$34K	Buy	+3,300	New	+$39.1K	﹤0.01%	2023

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

STRS Ohio's FENC Position: Q1 2026 in Review

STRS Ohio held its Fennec Pharmaceuticals (FENC) position steady in Q1 2026 at 5,200 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

STRS Ohio first reported a position in FENC in Q2 2018 and has held it in 11 quarters since. The position peaked at $129K in Q2 2020. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

STRS Ohio held 5,200 shares of Fennec Pharmaceuticals worth $32K as of Q1 2026.
STRS Ohio left its Fennec Pharmaceuticals share count unchanged in Q1 2026.
Fennec Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #2012 holding.
STRS Ohio first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 11 quarters since.
STRS Ohio's Fennec Pharmaceuticals position peaked at $129K in Q2 2020.
90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.